Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab

Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab

Bibliographic Details
Main Authors: Moataz Ellithi, Mahum Shahid, Hafez Mohammad Abdullah, Jonathan Bleeker
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137920300286
id doaj-5a5283ba394d473398a66873529a3b94
record_format Article
spelling doaj-5a5283ba394d473398a66873529a3b942021-09-17T04:37:30ZengElsevierHematology, Transfusion and Cell Therapy2531-13792021-07-01433364367Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumabMoataz Ellithi0Mahum Shahid1Hafez Mohammad Abdullah2Jonathan Bleeker3Corresponding author at: Department of Medicine, University of South Dakota Sanford School of Medicine, 1400 West 22nd Street, Sioux Falls, SD 57105, United States.; University of South Dakota, Sanford School of Medicine, Sioux Falls, United StatesUniversity of South Dakota, Sanford School of Medicine, Sioux Falls, United StatesUniversity of South Dakota, Sanford School of Medicine, Sioux Falls, United StatesUniversity of South Dakota, Sanford School of Medicine, Sioux Falls, United Stateshttp://www.sciencedirect.com/science/article/pii/S2531137920300286
collection DOAJ
language English
format Article
sources DOAJ
author Moataz Ellithi
Mahum Shahid
Hafez Mohammad Abdullah
Jonathan Bleeker
spellingShingle Moataz Ellithi
Mahum Shahid
Hafez Mohammad Abdullah
Jonathan Bleeker
Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
Hematology, Transfusion and Cell Therapy
author_facet Moataz Ellithi
Mahum Shahid
Hafez Mohammad Abdullah
Jonathan Bleeker
author_sort Moataz Ellithi
title Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
title_short Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
title_full Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
title_fullStr Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
title_full_unstemmed Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
title_sort complement c3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
publisher Elsevier
series Hematology, Transfusion and Cell Therapy
issn 2531-1379
publishDate 2021-07-01
url http://www.sciencedirect.com/science/article/pii/S2531137920300286
work_keys_str_mv AT moatazellithi complementc3mutationcausingatypicalhemolyticuremicsyndromesuccessfullytreatedwitheculizumab
AT mahumshahid complementc3mutationcausingatypicalhemolyticuremicsyndromesuccessfullytreatedwitheculizumab
AT hafezmohammadabdullah complementc3mutationcausingatypicalhemolyticuremicsyndromesuccessfullytreatedwitheculizumab
AT jonathanbleeker complementc3mutationcausingatypicalhemolyticuremicsyndromesuccessfullytreatedwitheculizumab
_version_ 1717377644636405760

Similar Items